NEUROPATHY IN METABOLIC SYNDROME AND NON-DIABETIC DISGLYCEMIA

Revista de la Sociedad Argentina de Diabetes

Marcela Giménez Rey¹  Carlos Santillán²  Raquel Urdaneta³  Concepción García³  Carolina Domínguez³  Claudia Flores⁴  Solange Houssay⁵  Fernanda Huber⁶  Graciela Fuente⁷ 

[1] Hospital Domingo Mercante, Provincia de Buenos Aires, Argentina;Hospital Dr. Leónidas Lucero, Bahía Blanca, Provincia de Buenos Aires, Argentina;Hospital Durand, Ciudad Autónoma de Buenos Aires;Hospital Penna, Bahía Blanca, Provincia de Buenos Aires;Hospital Tornú y Clínica San Camilo, Ciudad Autónoma de Buenos Aires;Sociedad Argentina de Diabetes, Ciudad Autónoma de Buenos Aires;Unidad de Nutrición del Hospital C. Durand, Ciudad Autónoma de Buenos Aires;

关键词: neuropatía diabética;    síndrome metabólico;    disglucemia no diabética.;   

DOI  :  10.47196/diab.v49i2.202

来源: DOAJ

【 摘 要 】

Diabetic neuropathy (DN) is the most common and early microvascular alteration associated to diabetes mellitus (DM); however, this event is most missed and less diagnosed. At the same time, it is widely known that metabolic syndrome (MS) is highly prevalent and the relationship between this status and macrovascular commitment is documented. The Diabetic Neuropathy Committee is focused in analyzing the neuropathic effect within the framework of MS and in one of its components such as non-diabetic disglycemia. The under diagnosis and increase of morbidity and mortality risk of these patients alert the medical community of the existence of this microvascular alteration exceeding the DM framework and is also present in MS and disglycemia either at fasting and postprandial.

【 授权许可】

Unknown